Inlecitug, CAS 2997627-68-4

Product Description: Inlecitug is a chimeric monoclonal antibody targeting human KDR (kinase insert domain receptor). Inlecitug specifically binds to KDR, blocking the binding of vascular endothelial growth factor (VEGF) to KDR and inhibiting angiogenesis, thus exerting antitumor activity. Inlecitug is promising for research of cancers[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.

CAS Number: 2997627-68-4

Molecular Weight: N/A

Research Area: Cancer

Target: VEGFR

• Artikelnummer: MEXHY-P991141-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991141-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated